반응식
[C:1]1([C:7]2[S:8][CH:9]=[C:10]([C:12]([C:14]3[CH:19]=[C:18]([O:20][CH3:21])[C:17]([O:22][CH3:23])=[C:16]([O:24][CH3:25])[CH:15]=3)=[O:13])[N:11]=2)[CH:6]=[CH:5][CH:4]=[CH:3][CH:2]=1.C(#N)C1C=C[C:30]([C:31]#[N:32])=CC=1.N[C@H](C(O)=O)CS>>[CH3:25][O:24][C:16]1[CH:15]=[C:14]([CH:19]=[C:18]([O:20][CH3:21])[C:17]=1[O:22][CH3:23])[C:12]([C:10]1[N:11]=[C:7]([C:1]2[CH:6]=[CH:5][C:4]([CH2:30][C:31]#[N:32])=[CH:3][CH:2]=2)[S:8][CH:9]=1)=[O:13]참가 물질
4
실험 절차
2-(4-(4-(3,4,5-Trimethoxybenzoyl)thiazol-2-yl)phenyl)acetonitrile (2n) was prepared using the same method as used of compound 1h from terephthalonitrile and cysteine. 1H NMR (500 MHz, CDCl3) δ 8.30 (s, 1H), 8.04 (d, 2H), 7.76 (s, 2H), 7.46 (d, 2H), 3.97 (s, 3H), 3.95 (s, 6H), 3.83 (s, 2H).
출처 및 근거
- ORD 기록
- ord-aa2bcf7a3f0d4325bdbafbfcb4f99bbb
- 출처 데이터셋
- uspto-grants-2014_09
- 특허 번호
- US08822513B2
연결된 노트
불러오는 중…